A citation-based method for searching scientific literature

Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
Times Cited: 96







List of co-cited articles
1395 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
40

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Carlos Cepeda, Raymond S Hurst, Christopher R Calvert, Elizabeth Hernández-Echeagaray, Oanh K Nguyen, Emily Jocoy, Lindsey J Christian, Marjorie A Ariano, Michael S Levine. J Neurosci 2003
253
37

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
244
37

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
583
35

Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
35

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
33

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
199
32

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
436
30

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
230
30

Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
735
30

Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease.
Véronique M André, Yvette E Fisher, Michael S Levine. Front Syst Neurosci 2011
58
46

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
25

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
119
23

Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice.
Austen J Milnerwood, Clare M Gladding, Mahmoud A Pouladi, Alexandra M Kaufman, Rochelle M Hines, Jamie D Boyd, Rebecca W Y Ko, Oana C Vasuta, Rona K Graham, Michael R Hayden,[...]. Neuron 2010
343
23

The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
23

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
80
28

Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Carlos Cepeda, Véronique M André, Irene Yamazaki, Nanping Wu, Max Kleiman-Weiner, Michael S Levine. Eur J Neurosci 2008
134
22


Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
Liliana B Menalled, Jessica D Sison, Ioannis Dragatsis, Scott Zeitlin, Marie-Françoise Chesselet. J Comp Neurol 2003
332
21

Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
Rona K Graham, Mahmoud A Pouladi, Prasad Joshi, Ge Lu, Yu Deng, Nan-Ping Wu, Bryan E Figueroa, Martina Metzler, Véronique M André, Elizabeth J Slow,[...]. J Neurosci 2009
94
20

Dichotomous anatomical properties of adult striatal medium spiny neurons.
Tracy S Gertler, C Savio Chan, D James Surmeier. J Neurosci 2008
281
18

Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.
J A Bibb, Z Yan, P Svenningsson, G L Snyder, V A Pieribone, A Horiuchi, A C Nairn, A Messer, P Greengard. Proc Natl Acad Sci U S A 2000
235
18

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
259
18


Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
G A Laforet, E Sapp, K Chase, C McIntyre, F M Boyce, M Campbell, B A Cadigan, L Warzecki, D A Tagle, P H Reddy,[...]. J Neurosci 2001
204
17

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
J G Hodgson, N Agopyan, C A Gutekunst, B R Leavitt, F LePiane, R Singaraja, D J Smith, N Bissada, K McCutcheon, J Nasir,[...]. Neuron 1999
632
17

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
147
17

Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease.
Damian M Cummings, Austen J Milnerwood, Glenn M Dallérac, Verina Waights, Jacki Y Brown, Sarat C Vatsavayai, Mark C Hirst, Kerry P S J Murphy. Hum Mol Genet 2006
87
18

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.
Carlos Cepeda, Amaal J Starling, Nanping Wu, Oanh K Nguyen, Besim Uzgil, Takahiro Soda, Veronique M André, Marjorie A Ariano, Michael S Levine. J Neurosci Res 2004
102
15

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.
Michael S Levine, Carlos Cepeda, Miriam A Hickey, Sheila M Fleming, Marie-Françoise Chesselet. Trends Neurosci 2004
126
15

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Michael A Johnson, Vignesh Rajan, Charles E Miller, R Mark Wightman. J Neurochem 2006
95
15

Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.
Y P Deng, R L Albin, J B Penney, A B Young, K D Anderson, A Reiner. J Chem Neuroanat 2004
143
15


Modulation of striatal projection systems by dopamine.
Charles R Gerfen, D James Surmeier. Annu Rev Neurosci 2011
914
15

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
230
15


Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
14

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
H Diana Rosas, David S Tuch, Nathanael D Hevelone, Alexandra K Zaleta, Mark Vangel, Steven M Hersch, David H Salat. Mov Disord 2006
242
14

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
544
14

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin.
Shu-ichi Okamoto, Mahmoud A Pouladi, Maria Talantova, Dongdong Yao, Peng Xia, Dagmar E Ehrnhoefer, Rameez Zaidi, Arjay Clemente, Marcus Kaul, Rona K Graham,[...]. Nat Med 2009
311
14

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
932
14

Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.
Anton Reiner, Evan Shelby, Hongbing Wang, Zena Demarch, Yunping Deng, Natalie Hart Guley, Virginia Hogg, Richard Roxburgh, Lynette J Tippett, Henry J Waldvogel,[...]. Mov Disord 2013
59
23


Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Joshua L Plotkin, Michelle Day, Jayms D Peterson, Zhong Xie, Geraldine J Kress, Igor Rafalovich, Jyothisri Kondapalli, Tracy S Gertler, Marc Flajolet, Paul Greengard,[...]. Neuron 2014
119
14




Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.
G Schilling, M W Becher, A H Sharp, H A Jinnah, K Duan, J A Kotzuk, H H Slunt, T Ratovitski, J K Cooper, N A Jenkins,[...]. Hum Mol Genet 1999
582
13

Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.
Benjamin R Miller, Adam G Walker, Anand S Shah, Scott J Barton, George V Rebec. J Neurophysiol 2008
87
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.